Compare OVV & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVV | PEN |
|---|---|---|
| Founded | 2020 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 12.9B |
| IPO Year | 2019 | 2015 |
| Metric | OVV | PEN |
|---|---|---|
| Price | $56.93 | $331.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 17 |
| Target Price | $57.88 | ★ $357.33 |
| AVG Volume (30 Days) | ★ 3.9M | 554.0K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.98% | N/A |
| EPS Growth | 13.54 | ★ 1155.56 |
| EPS | ★ 4.78 | 4.52 |
| Revenue | ★ $8,908,000,000.00 | $1,403,665,000.00 |
| Revenue This Year | $3.41 | $14.34 |
| Revenue Next Year | N/A | $13.71 |
| P/E Ratio | ★ $12.67 | $73.06 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $30.78 | $221.26 |
| 52 Week High | $62.60 | $362.41 |
| Indicator | OVV | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 51.57 | 39.53 |
| Support Level | $37.18 | $326.58 |
| Resistance Level | $62.60 | $338.99 |
| Average True Range (ATR) | 1.87 | 2.38 |
| MACD | -0.47 | -0.38 |
| Stochastic Oscillator | 19.89 | 32.73 |
Ovintiv Inc is a North American oil and natural gas exploration and production company focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs, and natural gas. The company has two operating segments: USA Operations and Canadian Operations. USA Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within the United States. Canadian Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within Canada. The company generates the majority of its revenue from USA Operations.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.